Teva and Royalty Pharma partner to speed up a vitiligo treatment's development.

Healthcare stocks rise in early 2026 due to aging populations and medical innovation.

FDA grants breakthrough status to Ipsen’s drug for unfit acute myeloid leukemia.

UF researchers found a gut-derived molecule that boosts lung cancer immunotherapy in mice, shrinking tumors by 50% in resistant cases.

A cholera toxin slowed tumor growth in mice by targeting cancer cells and boosting immunity without side effects, offering hope for safer cancer treatments.

China finalizes bulk purchase of 440 medical devices, cutting costs and expanding access by May 2026.

Celltrion expands U.S. operations, boosts drug capacity, and advances oncology pipeline with FDA-reviewed candidates.

LIR Life Sciences partners with Neuland Labs to develop non-injectable, patch-based obesity treatment using cell-penetrating peptides, backed by a $230,000 Phase 1 budget.

A new Swiss method tracks how antibiotics kill individual bacteria in real time, showing it better predicts treatment success than old tests.

Afghanistan to build $8.7M medical university in Khost with hospital and five faculties.